-
Views
-
Cite
Cite
Wei‐Cheng Fang, Sheng‐Yiao Lin, Shu‐Mei Huang, Cheng‐Che E. Lan, Low‐dose tofacitinib with 308‐nm excimer therapy successfully induced repigmentation in patients with refractory vitiligo, Clinical and Experimental Dermatology, Volume 47, Issue 4, 1 April 2022, Pages 782–783, https://doi.org/10.1111/ced.15070
- Share Icon Share
Abstract
Combining low‐dose tofacitinib with 308‐nm excimer may be an effective treatment for patients with nonsegmental vitiligo who were refractory to conventional therapies.
© 2022 British Association of Dermatologists
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
You do not currently have access to this article.